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1. Introduction 
Adenosine has been known for some time to acti- 
vate adenylate cyclase through its interaction with 
adenosine receptors [l-8] . In experiments con- 
ducted in our laboratory we have occasionally 
observed that if one eliminates theophylline from the 
adenylate cyclase assay of turkey erythrocyte mem- 
branes significant basal activities are observed. Where- 
as in the presence of 1 .O-2.0 mM theophylline or 
adenosine antagonists [3], the turkey erythrocyte 
adenylate cyclase exhibits a basal activity of less 
than 1 .O pmol cAMP/min/mg, in the absence of 
theophylline values of up to 100 pmol/min/mg could 
be observed. In the presence of adenosine deaminase 
the basal activity of these preparations could be 
diminished to values similar to those observed in the 
presence of theophylline. Due to the fact that not 
every membrane preparation could be stimulated by 
adenosine we sought a more definite experiment 
which would determine whether an adenosine recep- 
tor exists in these cells. We indeed found that in 
every membrane preparation of turkey erythrocytes 
the adenylate cyclase could be activated to its per- 
manently active form [9-lo] by adenosine and 
GppNHp. The ability of adenosine and GppNHp to 
activate the adenylate cyclase in a synergistic fashion 
was found to be very similar to the process of enzyme 
activation by 1-epinephrine and GppNHp [9-lo] . 
As reported previously [9-lo] GppNHp alone can- 
not induce enzyme activation. The preliminary charac- 
terization of this process is the subject of this com- 
munication. 
Abbreviations: GppNHp, guanylylimidodiphosphate 
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2. Materials and methods 
[(w-~*P]ATP was obtained from Radiochemical 
Centre (Amersham, England). All chemicals used were 
of the highest degree of purity available. All solutions 
were prepared in Corning doubly distilled water. 
Adenylate cyclase was assayed according to Salomon 
et al. [ 1 l] and protein was determined according to 
Lowry et al. [ 121. Turkey erythrocyte membranes 
were prepared as previously described [ 131. Other 
experimental details are given in the legends to the 
figures. 
3. Results 
3.1. The activation of adenylate cyclase by adenosine 
and CppNHp 
When turkey erythrocyte membranes are incubated 
with increasing concentrations of adenosine, in the 
presence of saturating GppNHp, the adenylate cyclase 
is activated to its permanently active form (fig.1). The 
process of activation can be stopped at any time by 
the addition of theophylline, an adenosine antagonist 
[3]. Theophylline, however, is unable to revert the 
permanently active enzyme back to its inactive form. 
Since DL-propranolol was present during all incuba- 
tions the possibility that the adenosine effect is 
through the fi-adrenergic receptors can be ruled out. 
The maximal level of activation attainable by adeno- 
sine plus GppNHp is 70% of the maximal level attain- 
able with 1-epinephrine and GppNHp. Other nucleo- 
sides such as guanosine were found to be without any 
effect on the adenylate cyclase system. 
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TIME (minutes) 
Fig. 1. Kinetics of adenylate cyclase activation by adenosine 
and GppNHp. Turkey erythrocyte membranes at a final con- 
centration of 0.72 mg/ml were preincubated with 1.0 X 10m5 M 
GppNHp in 50 mM Tris-HCI buffer, pH 7.4, containing 
2 mM MgCI, and 1 mM EDTA, at 37°C. At zero time adeno- 
sine in the same buffer at a final concentration indicated in 
the figure was added, also after prior incubation at 37°C. At 
time points indicated by the experimental points, theophyl- 
line at a final concentration of 1.1 mg/ml was added, to stop 
the activation process. Adenylate cyclase activity was then 
measured in these samples in the presence of 0.58 mg/ml 
theophylline final concentration. The assay also contained 
1.0 X lo-’ M DL-propranolol. The dashed arrows indicate 
that the non-activated enzyme, remaining after theophylline 
addition can be activated by the addition of 1-epinephrine, 
to its maximal attainable specific activity. (-o-o-) Control, 
containing 2.2 mM theophylline plus 1.0 X 10e5 DL-propra- 
nolol and 1.0 X 10e5 M GppNHp. (-B-B-) Control containing 
2.2 mM theophylline plus 1.0 X 10m5 M GppNHp. (-o-o-) 
1.0 X lo-’ M adenosine. (-A-A-) 1.0 X 10m6 M adenosine. 
(-b-A-) !.O X lo-’ M adenosine. (-m-m-) 1 .O X lo-* M adeno- 
sine. (-o-o-) 1.0 X 1O-5 M 1-epinephrine. 
3.2. The rate of enzyme activation by adenosine 
The rate of adenylate cyclase activation by adeno- 
sine, in the presence of GppNHp, is maximal at 
1 .O X lo4 M and half-maximal between 1 .O X 10m6 M 
and 1 .O X lo-’ M (fig.1). This indicates that the 
affinity of adenosine to its receptor is between 1 PM 
and 10 PM. The maximal rate of activation by adeno- 
sine is much slower than the maximal rate of activa- 
tion induced by 1 -epinephrine and GppNHp. 
3.3. The combined action of adenosine and 
I-epinephrine 
4. Discussion 
I-Epinephrine at I .O X 1O-7 M and adenosine at 4.1. The pattern of adenosine activation 
1 .O X 10T6 M activate adenylate cyclase at comparable Turkey erythrocyte membranes possess both a 
rates (fig.2) in the presence of GppNHp. It can be /3-adrenergic receptor and an adenosine receptor. The 
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Fig.2. The combined activation of adenylate cyclase by 
adenosine and 1-epinephrine, in the presence of GppNHp. The 
experimental details are similar to those given in the legend 
to fig. 1. All reaction mixtures contained 1 .O X IO-’ M 
GppNHp final concentration. The adenosine and l-epi- 
nephrine concentrations used in this experiment were 
1.0 X 10m6 M and 1.0 X 10“ M, respectively. When adenosine 
was used alone the process of enzyme activation was stopped 
by theophylline and when the enzyme activation was induced 
by 1-epinephrine alone the reaction was stopped with 
1.0 X 10e5 M DL-propranolol. When the enzyme activation 
was induced by both adenosine and I-epinephrine the reac- 
tion was stopped by a mixture of 1.0 X IO-’ M DL-propra- 
nolo1 and 1.1 mg/ml theophylline final concentration. 
(-o-o-) 1.0 X 10e6 M adenosine. (-a-~-) 1.0 X 10“ M I-epin- 
cphrine. (-A-A-) 1.0 X 10e6 M adenosine and 1.0 X 10.’ M 
1-epinephrine. (-o-o-) 1.0 X 10m5 M GppNHp. (-o-o-) 
1.0 X lo-’ M GppNHp plus 1.0 X lo-’ M propranolol and 
1 .l mg/ml theophylline. 
seen that when the two ligands are combined the rate 
of enzyme activation is less than the sum of the 
rates of activation induced by the two ligands sepa- 
rately (fig.2). This finding indicates that the two 
receptors compete for a common pool of enzyme and 
their effect is not additive. This non-additivity of the 
adenosine and epinephrine action could be demon- 
strated over a wide concentration of the two ligands. 
The concentrations used in the experiment described 
in fig.2 are in the most sensitive range for the detec- 
tion of additivity. 
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occupancy of these receptors by either adenosine or 
1 -epinephrine induce the activation of the enzyme 
adenylate cyclase. Adenosine in the presence of 
GppNHp induces the activation of adenylate cyclase 
to a permanently active state by amichanism similar 
to the process of adenylate cyclase activation by 
1 -epinephrine and GppNHp [9-lo] . Theophylline, 
an adenosine antagonist, inhibits the process of 
enzyme activation by adenosine and GppNHp but is 
unable to revert the permanently active enzyme 
back to its inactive form. This pattern of behavior of 
the adenosine antagonist is similar to the behavior of 
propranolol with respect to the process of enzyme 
activation by I-epinephrine and GppNHp [9-lo] . 
tion of a permanently active adenylate cyclase. This 
effect of adenosine is inhibited by the adenosine 
antagonist theophylline but the latter is unable to 
revert the enzyme to its inactive state. 70% of the 
total adenylate cyclase pool was found to be sensi- 
tive to adenosine whereas the remaining 30% could 
be activated only by 1-epinephrine and GppNHp. All 
of the enzyme pool could be activated by 1 -epinephrine 
and GppNHp. The combined action of adeno- 
sine and 1-epinephrine indicates that their action is 
not additive and both compete for a common pool 
of adenylate cyclase. 
4.2. The non-additivity of adenosine and epinephrine Acknowledgement 
action 
Adenosine is capable to activate 70% of the enzyme 
pool to its permanently active state, in the presence 
of GppNHp (fig.1). All of the enzyme pool, however, 
can be activated to its permanently active state by 
1-epinephrine and GppNHp (fig.1). Thus the maxi- 
mal activity attainable in the presence of both l-epi- 
nephrine and adenosine and in the presence of GppNHp 
is identical to the maximal activity attainable with 
1 -epinephrine alone, in the presence of GppNHp 
(fig.1 and 2). When both adenosine and I-epinephrine 
are present together, the rate of enzyme activation 
in the presence of GppNHp, is less than the sum of 
rates of the two ligands, when present separately 
(fig.2). The non-additivity of the adenosine and the 
1 -epinephrine effects is observed over a wide con- 
centration range of adenosine and 1 -epinephrine. 
These results indicate that the two receptors com- 
pete for a common pool of adenylate cyclase. It 
seems that the turkey erythrocyte system can become 
a suitable model system to study the mode of inter- 
action of one adenylate cyclase with two different 
receptors. 
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